The SMARCA4-deletion patient was diagnosed with synovial sarcoma of the ovary, revised to small-cell carcinoma based on this study, and would have fulfilled both criteria if the initial diagnosis had been correct. This evidence concerns the gene SMARCA4 and small cell carcinoma.